Topic Hub
25 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 25 of 25 clinical reviews.
A clinician-reviewed guide to how methimazole affects appetite and food cravings in hyperthyroid patients, including the thyroid-metabolic axis, expected timelines, and when appetite changes signal a problem.
Read clinical reviewA physician-level review of methimazole's autoimmune mechanisms, drug-induced immune reactions, monitoring protocols, and clinical decision-making for patients with Graves disease and co-existing autoimmune conditions.
Read clinical reviewA clinician-reviewed guide to how methimazole affects bone mineral density, fracture risk, and skeletal outcomes in hyperthyroidism management, with primary-literature citations and practical monitoring guidance.
Read clinical reviewA clinician-level review of the evidence on methimazole and cancer risk, covering thyroid cancer signals, hematologic concerns, epidemiologic data, and what current guidelines recommend for patients on long-term antithyroid therapy.
Read clinical reviewA clinician-level review of how methimazole treats hyperthyroidism, reverses cardiac remodeling, and reduces long-term cardiovascular risk. Includes trial data, dosing guidance, and an original decision framework.
Read clinical reviewA clinical review of how methimazole treats hyperthyroidism and what the evidence says about its effects on brain fog, memory, mood, and overall cognitive function in Graves disease and toxic thyroid states.
Read clinical reviewA physician-reviewed comparison of compounded methimazole versus branded Tapazole covering bioavailability, cost, dosing, safety, and when each formulation is appropriate for hyperthyroidism and Graves disease management.
Read clinical reviewA GRADE-graded review of methimazole (Tapazole) for hyperthyroidism and Graves disease, covering randomized trial data, guideline recommendations, dosing, adverse effects, and clinical decision-making at MD/PharmD depth.
Read clinical reviewA full clinical review of methimazole-induced and hyperthyroidism-related hair and skin changes, including alopecia, urticaria, and vasculitis, with primary-literature citations and management guidance.
Read clinical reviewA physician-reviewed guide to how methimazole affects liver function, covering hepatotoxicity risk, monitoring protocols, drug comparisons, and management of abnormal LFTs during hyperthyroidism treatment.
Read clinical reviewA clinician-level review of how methimazole affects anxiety, depression, cognition, and emotional regulation in hyperthyroid patients, with primary-literature citations and dosing guidance.
Read clinical reviewHow methimazole restores thyroid-driven metabolic control, what happens to BMR, thermogenesis, and body weight during treatment, and what clinicians need to know about monitoring and dosing.
Read clinical reviewA physician-reviewed, evidence-based deep dive into methimazole microdosing protocols for hyperthyroidism and Graves disease, including dose ranges, remission data, titration strategies, and where the evidence is thin.
Read clinical reviewA clinician-level guide to preventing and reversing hyperthyroidism-driven muscle loss during methimazole therapy, with primary-literature citations, dosing protocols, and resistance-training guidance.
Read clinical reviewA physician-level guide to diagnosing and managing methimazole plateau and non-response in hyperthyroidism and Graves disease, with primary-literature citations and a clinical decision framework.
Read clinical reviewA physician-level review of methimazole (Tapazole) pharmacokinetics, dosing adjustments, and monitoring protocols after bariatric surgery, with primary-literature citations and clinical decision guidance.
Read clinical reviewA physician-level guide to the methimazole pre-surgery hold window for hyperthyroidism and Graves disease: when to stop, when to restart, iodine loading, and how to avoid thyroid storm.
Read clinical reviewA full clinical guide to methimazole rebound hyperthyroidism after stopping treatment: who is at risk, what the evidence shows, how to taper safely, and when to escalate to definitive therapy.
Read clinical reviewDoes methimazole protect the kidneys or harm them? A physician-reviewed, primary-literature analysis of methimazole's renal effects in hyperthyroidism and Graves disease, including GFR changes, ANCA-associated vasculitis risk, and dosing guidance.
Read clinical reviewA clinician-level guide to how seasonal variation in thyroid hormone levels, illness, sun exposure, and lifestyle shifts affect methimazole dosing and monitoring throughout the year.
Read clinical reviewA clinician-level review of how methimazole affects libido, erectile function, menstrual cycles, and fertility, with primary-literature citations, real doses, and practical management steps.
Read clinical reviewA clinical deep-dive into how methimazole treats hyperthyroidism and reshapes sleep architecture: what the evidence shows on slow-wave sleep, REM cycles, nocturnal awakenings, and what thyroid normalization means for your patients' nights.
Read clinical reviewA clinician-level guide to timing methimazole doses across time zones, managing missed doses during travel, and monitoring thyroid function when itineraries disrupt routine schedules.
Read clinical reviewA clinician-level guide to safely restarting methimazole after acute illness, including CBC thresholds, dosing protocols, and drug interaction checks, reviewed by the HealthRX medical team.
Read clinical reviewA clinician-reviewed, week-by-week guide to methimazole (Tapazole) for hyperthyroidism and Graves disease. Learn what symptoms improve first, when labs shift, and which warning signs need same-day care.
Read clinical review